Partnerships
Financial assessment
All relevant details are outlined below.
Financial assessment
As part of the evaluation of EANM’s eligibility to participate in EMA activities, the following financial information is provided for assessment, based on data from the 2024 financial year:
Non-industry income: 4.032.768,96 €
Split of non-industry income (in % of total income):
- Registration fees: 41,06%
- Membership fees: 4,25%
- Educational events: 1,92%
- Donations: 0.06%
- Other income (including EU projects funding): 3,79%
Industry income: 3.862.301,93 €
Split of industry income (in % of total income):
- Congress and events: 41,16%
- Grants for INSPIRE: 3,48%
- Corporate membership: 4,27%
The highest contribution from a single company is 2,88% of the overall income.
The overall proportion of industry vs non-industry income in 2024 was 48,92% vs 51,08%.
Industry partners 2024
The following companies provided financial contributions to EANM:
A.C.O.M. Advanced Center Oncology Macerata S.r.l. |
ABX advanced biochemical compounds |
ABX-CRO advanced pharmaceutical services Forschungsgesellschaft mbH |
Advanced Accelerator Applications Molecular Imaging Italy S.r.l. |
Advanced Accelerator Applications, A Novartis Company |
Advanced Cyclotron Systems Inc. |
Agilera Pharma AS |
Aixial Group Limited |
Alliance Medical GmbH |
ALMAC GROUP |
Artbio Inc. |
Associated Couriers, LLC |
AtomVie Global Radiopharma Inc. |
AWEX – Wallonia Export & Investment Agency |
Bayer AG |
Becquerel & Sievert Inc., Ltd |
Berthold Technologies GmbH & Co. KG |
Blue Earth Diagnostics Ltd. |
Boston Scientific International SA |
Brightonix Imaging Inc |
Bruker BioSpin GmbH & Co. KG |
BWXT Medical |
Canadian Nuclear Isotope Council |
Candex for Novartis Pharma AG |
Capintec, Mirion Technologies, Inc. |
Chelatec SAS |
CHEMATECH |
China Isotope & Radiation Corporation (CIRC) |
CMR – Center of Molecular Research Corporation GmbH |
COMECER SpA |
Crystal Photonics GmbH |
cts GmbH – competence for technical solutions |
CUP Laboratorien Dr. Freitag GmbH / TRIMT GmbH |
Curium PET Europe SAS |
Cyclomedica Europe Ltd. |
diXit s.r.l. |
DOSIsoft SA |
Dyckerhoff Pharma GmbH & Co. KG |
EARL |
ec2 Software Solutions |
Eckert & Ziegler Radiopharma GmbH |
EDL |
Eichrom Technologies |
EITA (European Isotopes Transport Association) |
Eli Lilly and Company |
ELSE Solutions S.r.l. |
Esco Micro Pte. Ltd |
Evergreen Theragnostics, Inc. |
Full-Life Technologies GmbH |
Gamma Medical Technology |
GE Healthcare |
GE Healthcare SCS Medical Systems |
GENERAL EQUIPMENT FOR MEDICAL IMAGING S.A |
Getinge Life Science France (LaCalhene) |
Grupo RPH |
Hamburg Tourismus |
Hermes Medical Solutions AB |
IBA SA |
IBC Advanced Technologies, Inc. |
ICPO |
ImaginAb |
Institute of Isotopes Co. Ltd. |
Inter Medical Medizintechnik GmbH |
INVIA Medical Imaging Solutions |
Invicro |
inviscan |
Ionetix Alpha |
Iotron Medical Inc |
iPHASE Technologies |
isoSolutions Marketing & Management Inc. |
Isotope JSC – no further contribution expected in the coming years |
Isotopia Molecular Imaging Ltd. |
ITEL Telecomunicazioni SRL |
ITM Pharma Solutions GmbH |
Jiangsu Huayi Technology Co., Ltd. |
LabLogic Systems Ltd. |
Lantheus |
Lemer Pax |
Life Molecular Imaging Ltd. |
Longevous Beamtech Co.Lt |
Lynax sro. |
MCI SUISSE SA |
MDPI AG |
Medi-Radiopharma Ltd. |
Mediso Medical Imaging Systems |
Medscape LLC |
MedTrace Pharma AS |
MIAS Pharma |
MiE medical imaging electronics GmbH |
MILabs B.V. |
MIM Software Inc. |
Minerva Imaging |
MNT Healthcare Services Inc |
MR Solutions Ltd. |
Novartis |
NRGPALLAS Medical isotopes |
Nuclear Medicine Europe |
Nuclear Shields BV |
Nusano Inc. |
OncoBeta GmbH |
Oncodesign |
OncoSil Medical Europe GmbH |
Optimized Radiochemical Applications |
Pars Isotope Co. – contribution under review by the EANM Board |
PBL Srl. |
Pfizer Inc. |
PI Medical Diagnostic Equipment B.V. |
piCHEM Forschungs- und Entwicklungs gmbH |
PMB-ALCEN |
POLATOM, Radioisotope Centre of National Centre for Nuclear Research |
Positrigo AG |
Radqual |
rapp-iso GmbH |
RayzeBio Inc |
RescueDose Ltd |
Rotem GmbH |
ROTOP Pharmaka GmbH |
RoweMed AG – Medical 4 Life |
RPO Clinical |
RQS Alexander Ruffani |
Scintomics GmbH |
SCK CEN |
SHINE Medical Technologies, LLC |
Siemens Healthineers AG |
Sirtex Medical Europe GmbH |
SpectronRx |
Spectrum Dynamics Medical Inc. |
Sumitomo Heavy Industries, Ltd. |
SYNTHRA GmbH |
Taiyo Nippon Sanso Corporation |
Telix Innovations SA |
Telix Pharmaceuticals (US) Inc. |
TEMA Sinergie S.p.A. |
TerraPower |
TerThera b.v. |
Terumo Europe NV |
TRASIS S.A. |
Triskem International |
TRUKING TECHNOLOGY LIMITED |
U.S. Department of Energy Isotope Program (OAK Ridge) |
United Imaging |
United Imaging Healthcare Poland Sp. z o.o. |
United Well Biotechnology Shanghai Limited |
Urenco Stable Isotopes |
VICI AG |
Von Gahlen Nederland B.V. |
Voximetry |
Wällischmiller Engineering GmbH |
WOJCIECH KULA Axcellant |
Wolfgang Fendler |
Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. |
Xeos Medical NV |
Siemens (inspire) |
Nusano Inc. (inspire) |
Point Biopharma (inspire) |
Avid Radiopharmaceuticals (inspire) |